ArticleBMC ophthalmology2026

Cost-effectiveness of the Port Delivery Platform compared with intravitreal injection of anti-vascular endothelial growth factor for patients with neovascular age-related macular degeneration.

Michelle Mies Elisabeth Siekerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.